Baldwin Wealth Partners’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Baldwin Wealth Partners’s Portfolio TFFP Stock Details TFFP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-400	Closed	-$6.85K	–	804
2023 Q1	$6.85K	Hold	400	–	–	﹤0.01%	652
2022 Q4	$10.5K	Hold	400	–	–	﹤0.01%	604
2022 Q3	$41K	Hold	400	–	–	0.01%	355
2022 Q2	$57K	Hold	400	–	–	0.01%	336
2022 Q1	$63K	Hold	400	–	–	0.01%	342
2021 Q4	$89K	Hold	400	–	–	0.01%	282
2021 Q3	$77K	Hold	400	–	–	0.01%	293
2021 Q2	$96K	Hold	400	–	–	0.01%	276
2021 Q1	$136K	Hold	400	–	–	0.02%	227
2020 Q4	$143K	Buy	+400	New	+$154K	0.02%	214

Other funds holding TFFP

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Baldwin Wealth Partners's TFFP Position: Q2 2023 in Review

Baldwin Wealth Partners sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q2 2023, closing a stake of 400 shares — an estimated $6.85K sold.

Baldwin Wealth Partners first reported a position in TFFP in Q4 2020 and held it in 10 quarters. The position peaked at $143K in Q4 2020. 33 funds tracked by Wall St. Rank hold TFFP as of Q2 2023.

Baldwin Wealth Partners reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Baldwin Wealth Partners sold 400 TFF Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $6.85K.
Baldwin Wealth Partners first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 10 quarters.
Baldwin Wealth Partners's TFF Pharmaceuticals, Inc. Common Stock position peaked at $143K in Q4 2020.
33 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Baldwin Wealth Partners's 13F filing for Q2 2023, filed 14 Jul 2023.